首页> 外文OA文献 >Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting: The Nordic-Baltic Bifurcation Study III
【2h】

Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting: The Nordic-Baltic Bifurcation Study III

机译:主血管支架置入术治疗冠状动脉分叉病变患者终末吻合球囊扩张与未行终末吻合球囊扩张的随机比较:北欧-波罗的海分叉研究III

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background- It is unknown whether the preferred 1-stent bifurcation stenting approach with stenting of the main vessel (MV) and optional side branch stenting using drug-eluting stents should be finalized by a kissing balloon dilatation (FKBD). Therefore, we compared strategies of MV stenting with and without FKBD. Methods and Results- We randomized 477 patients with a bifurcation lesion to FKBD (n=238) or no FKBD (n=239) after MV stenting. The primary end point was major adverse cardiac events: cardiac death, non-procedure-related index lesion myocardial infarction, target lesion revascularization, or stent thrombosis within 6 months. The 6-month major adverse cardiac event rates were 2.1% and 2.5% (P=1.00) in the FKBD and no-FKBD groups, respectively. Procedure and fluoroscopy times were longer and more contrast media was needed in the FKBD group than in the no-FKBD group. Three hundred twenty-six patients had a quantitative coronary assessment. At 8 months, the rate of binary (re)stenosis in the entire bifurcation lesion (MV and side branch) was 11.0% versus 17.3% (P=0.11), in the MV was 3.1% versus 2.5% (P=0.68), and in the side branch was 7.9% versus 15.4% (P=0.039) in the FKBD versus no-FKBD groups, respectively. In patients with true bifurcation lesions, the side branch restenosis rate was 7.6% versus 20.0% (P=0.024) in the FKBD and no-FKBD groups, respectively. Conclusions- MV stenting strategies with and without FKBD were associated with similar clinical outcomes. FKBD reduced angiographic side branch (re)stenosis, especially in patients with true bifurcation lesions. The simple no-FKBD procedures resulted in reduced use of contrast media and shorter procedure and fluoroscopy times. Long-term data on stent thrombosis are needed. Clinical Trial Registration- URL: http://clinicaltrials.gov. Unique identifier: NCT00914199.
机译:背景-尚不清楚是否应通过接吻球囊扩张术(FKBD)来确定首选的1支架分叉支架术和主血管支架术(MV)以及可选的使用药物洗脱支架的侧支支架术。因此,我们比较了有无FKBD的MV支架置入策略。方法和结果-我们将477例分叉病变的患者在MV支架置入后分为FKBD(n = 238)或无FKBD(n = 239)。主要终点是主要的不良心脏事件:在6个月内,心脏死亡,与手术无关的指数病变心肌梗死,目标病变血运重建或支架血栓形成。 FKBD组和非FKBD组的6个月主要不良心脏事件发生率分别为2.1%和2.5%(P = 1.00)。与非FKBD组相比,FKBD组的手术和透视时间更长,并且需要更多的造影剂。 326例患者进行了定量冠状动脉评估。在8个月时,整个分叉病变(MV和侧支)的二元(再)狭窄率分别为11.0%和17.3%(P = 0.11),MV分别为3.1%和2.5%(P = 0.68), FKBD组和无FKBD组的侧支分别为7.9%和15.4%(P = 0.039)。在具有真正分叉病变的患者中,FKBD组和非FKBD组的侧支再狭窄率分别为7.6%和20.0%(P = 0.024)。结论伴或不伴FKBD的MV支架置入策略与相似的临床结果相关。 FKBD减少了血管造影侧支(再)狭窄,特别是对于真正的分叉病变患者。简单的无FKBD程序减少了造影剂的使用,缩短了程序和透视的时间。需要有关支架血栓形成的长期数据。临床试验注册-URL:http://clinicaltrials.gov。唯一标识符:NCT00914199。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号